Hanseok Ko

Hanseok Ko

Johns Hopkins University

H-index: 38

North America-United States

About Hanseok Ko

Hanseok Ko, With an exceptional h-index of 38 and a recent h-index of 34 (since 2020), a distinguished researcher at Johns Hopkins University, specializes in the field of Neurodegeneration and Parkinson's disease.

His recent articles reflect a diverse array of research interests and contributions to the field:

Stereotaxic α-Syn PFF injection into mouse striatum

Grip Strength

Cylinder Test

DJ-1 protects cell death from a mitochondrial oxidative stress due to GBA1 deficiency

Nest Building Test

Pathologic α–Synuclein–NOD2 Interaction and RIPK2 Activation Drives Microglia–Induced Neuroinflammation in Parkinson's Disease

Linking Gba1 E326K mutation to microglia activation and mild age-dependent dopaminergic Neurodegeneration

Advanced human iPSC-based preclinical model for Parkinson’s disease with optogenetic alpha-synuclein aggregation

Hanseok Ko Information

University

Position

Associate Professor of Neurology and ICE, Johns Hopkins School of Medicine

Citations(all)

13684

Citations(since 2020)

7547

Cited By

8964

hIndex(all)

38

hIndex(since 2020)

34

i10Index(all)

55

i10Index(since 2020)

51

Email

University Profile Page

Google Scholar

Hanseok Ko Skills & Research Interests

Neurodegeneration and Parkinson's disease

Top articles of Hanseok Ko

Stereotaxic α-Syn PFF injection into mouse striatum

2024/3/14

Grip Strength

2024/3/14

Cylinder Test

2024/3/14

DJ-1 protects cell death from a mitochondrial oxidative stress due to GBA1 deficiency

Genes & Genomics

2024/3/9

Nest Building Test

2024/2/7

Pathologic α–Synuclein–NOD2 Interaction and RIPK2 Activation Drives Microglia–Induced Neuroinflammation in Parkinson's Disease

bioRxiv

2024

Linking Gba1 E326K mutation to microglia activation and mild age-dependent dopaminergic Neurodegeneration

bioRxiv

2023/9/14

Advanced human iPSC-based preclinical model for Parkinson’s disease with optogenetic alpha-synuclein aggregation

Cell stem cell

2023/7/6

Mutant glucocerebrosidase impairs α-synuclein degradation by blockade of chaperone-mediated autophagy

Science Advances

2022/2/9

c-Abl Regulates the Pathological Deposition of TDP-43 via Tyrosine 43 Phosphorylation

Cells

2022/12/8

Levodopa-induced dyskinesia in Parkinson’s disease: pathogenesis and emerging treatment strategies

2022/11/23

Long-acting glp-1r agonist as a therapy of neurological and neurodegenerative conditions

2022/4/14

Correction to “A Novel, Selective c-Abl Inhibitor, Compound 5, Prevents Neurodegeneration in Parkinson’s Disease”

Journal of medicinal chemistry

2021/12/2

Inhibition of rip kinases for treating neurodegenerative disorders

2021/10/21

A novel, selective c-Abl inhibitor, compound 5, prevents neurodegeneration in Parkinson’s disease

Journal of medicinal chemistry

2021/9/29

Alpha-synuclein preformed fibrils induce cellular senescence in Parkinson’s disease models

Cells

2021/7/5

Complement and coagulation cascades are potentially involved in dopaminergic neurodegeneration in α-synuclein-based mouse models of Parkinson’s disease

Journal of proteome research

2021/6/1

Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer’s disease

Acta neuropathologica communications

2021/4/26

See List of Professors in Hanseok Ko University(Johns Hopkins University)

Co-Authors

academic-engine